0.63
Lyell Immunopharma, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
billions USD
FY21:
FY22:
0.65
FY23:
0.55
FY24:
0.38
FY25:
0.26
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.50
FY22:
0.29
FY23:
0.20
FY24:
0.11
FY25:
0.08
Total assets
Change from FY21 to FY25
billions USD
FY21:
1.13
FY22:
0.94
FY23:
0.75
FY24:
0.49
FY25:
0.34
Liabilities & Equity
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.05
FY22:
0.04
FY23:
0.03
FY24:
0.05
FY25:
0.05
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.15
FY22:
0.07
FY23:
0.06
FY24:
0.05
FY25:
0.04
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.93
FY22:
0.83
FY23:
0.65
FY24:
0.38
FY25:
0.25
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
1.13
FY22:
0.94
FY23:
0.75
FY24:
0.49
FY25:
0.34
All amounts in billions USD